Nektar Therapeutics

Connor, Clark & Lunn Investment Management Ltd. NKTR

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/12/2025

Shares

368,304

Value ($000)

250

Weight

0.0%

2014 Q1 - 2025 Q1 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/12/2025	250	0.0%	368,304	3/31/2025
2024 Q4	2/10/2025	680	0.0%	730,875	12/31/2024
2024 Q3	11/8/2024	846	0.0%	650,841	9/30/2024
2024 Q2	8/9/2024	764	0.0%	616,242	6/30/2024
2024 Q1	5/9/2024	536	0.0%	574,049	3/31/2024
2023 Q4	2/9/2024	281	0.0%	496,720	12/31/2023
2023 Q3	11/13/2023	293	0.0%	491,975	9/30/2023
2023 Q2	8/10/2023	365	0.0%	634,663	6/30/2023
2023 Q1	5/10/2023	315	0.0%	448,227	3/31/2023
2022 Q4	2/10/2023	365	0.0%	161,327	12/31/2022
2022 Q3	11/10/2022	34	0.0%	10,709	9/30/2022
2022 Q2	8/5/2022	144	0.0%	37,837	6/30/2022
2022 Q1	5/12/2022	908	0.0%	168,477	3/31/2022
2021 Q4	2/10/2022	717	0.0%	53,102	12/31/2021
2021 Q2	8/12/2021	270	0.0%	15,736	6/30/2021
2019 Q4	2/12/2020	554	0.0%	25,675	12/31/2019
2014 Q1	5/14/2014	171	0.0%	12,800	3/31/2014